{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:46Z","timestamp":1793814166935,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90089-x","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:08:49Z","timestamp":1743826129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Diagnostic accuracy of nanopore sequencing for detecting Mycobacterium tuberculosis and drug-resistant strains: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Timothy Hudson David Culasino","family":"Carandang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne Jaula","family":"Cunanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail S.","family":"Co","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John David","family":"Pilapil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca I.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Yotebieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi B.","family":"Torrelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Israel","family":"Notarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"90089_CR1","unstructured":"World health organization. global tuberculosis report 2021. Geneva: World health organization. Retrieved 21 February 2024 from (2021). https:\/\/www.who.int\/publications\/i\/item\/9789240037021"},{"key":"90089_CR2","unstructured":"World Health organization (WHO). Tuberculosis. Retrieved 23 February 2024 from (2024)., February 20 https:\/\/www.who.int\/health-topics\/tuberculosis#tab=tab_1"},{"key":"90089_CR3","unstructured":"Singh, S. et al. Challenges in tuberculosis diagnosis and management: recommendations of the expert panel. Nat. J. Mycol., 6(1\u20132), 1\u201311. Retrieved 22 February 2024 from (2015). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4411802\/"},{"key":"90089_CR4","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Accuracy of nanopore sequencing as a diagnostic assay for pulmonary tuberculosis versus Smear, Culture and Xpert (2023).","DOI":"10.3390\/tropicalmed8090441"},{"key":"90089_CR5","doi-asserted-by":"publisher","unstructured":"Yang, J. et al. Accuracy of nanopore sequencing as a diagnostic assay for pulmonary tuberculosis versus smear, culture and xpert \/ (2022). The value of GeneXpert MTB\/RIF for detection in tuberculosis: A bibliometrics-based analysis and review. J. Anal. Meth. Chem., 2022, 2915018. (2023). https:\/\/doi.org\/10.1155\/2022\/2915018","DOI":"10.1155\/2022\/2915018"},{"key":"90089_CR6","unstructured":"World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance (Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children): Policy Update. Retrieved 22 February 2024 from (2013). https:\/\/iris.who.int\/bitstream\/handle\/10665\/112472\/9789241506335_eng.pdf?sequence=1"},{"key":"90089_CR7","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Tuberculosis: Appendix 1. Xpert assays. MSF medical guidelines. Retrieved 24 May 2024 at (2024). https:\/\/medicalguidelines.msf.org\/en\/viewport\/TUB\/english\/appendix-3-xpert-mtb-rif-20323734.html."},{"issue":"2","key":"90089_CR8","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1093\/cid\/ciaa873","volume":"73","author":"BC Bisimwa","year":"2021","unstructured":"Bisimwa, B. C. et al. Xpert mycobacterium tuberculosis\/Rifampicin-detected rifampicin resistance is a suboptimal surrogate for multidrug-resistant tuberculosis in Eastern democratic republic of the congo: diagnostic and clinical implications. Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am. 73 (2), e362\u2013e370. https:\/\/doi.org\/10.1093\/cid\/ciaa873 (2021).","journal-title":"Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am."},{"key":"90089_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40291-023-00669-8","volume":"27","author":"J Chen","year":"2023","unstructured":"Chen, J. & Xu, F. Application of nanopore sequencing in the diagnosis and treatment of pulmonary infections. Mol. Diagn. Ther. 27, 685\u2013701. https:\/\/doi.org\/10.1007\/s40291-023-00669-8 (2023).","journal-title":"Mol. Diagn. Ther."},{"key":"90089_CR10","unstructured":"World Health Organization. Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: Rapid communication. Retrieved 23 February 2024 from (2023). https:\/\/iris.who.int\/bitstream\/handle\/10665\/371687\/9789240076372-eng.pdf?sequence=1"},{"key":"90089_CR11","doi-asserted-by":"publisher","unstructured":"Bogaerts, B. et al. Closing the gap: oxford nanopore technologies R10 sequencing allows comparable results to Illumina sequencing for SNP-based outbreak investigation of bacterial pathogens. J. Clin. Microbiol. 62 (e01576-23). https:\/\/doi.org\/10.1128\/jcm.01576-23 (2024).","DOI":"10.1128\/jcm.01576-23"},{"key":"90089_CR12","doi-asserted-by":"publisher","first-page":"954074","DOI":"10.3389\/fcimb.2022.954074","volume":"12","author":"C Nimmo","year":"2022","unstructured":"Nimmo, C. et al. Evolution of Mycobacterium tuberculosis drug resistance in the genomic era. Front. Cell. Infect. Microbiol. 12, 954074. https:\/\/doi.org\/10.3389\/fcimb.2022.954074 (2022). PMID: 36275027; PMCID: PMC9585206.","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"90089_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Zhao, Y., Bollas, A., Wang, Y. & Au, K. F. Nanopore sequencing technology, bioinformatics and applications. Nat. Biotechnol. 39 (11), 1348\u20131365. https:\/\/doi.org\/10.1038\/s41587-021-01108-x (2021).","journal-title":"Nat. Biotechnol."},{"key":"90089_CR14","doi-asserted-by":"crossref","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow,C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville,J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson,E., McDonald, S., McGuinness, L. A., \u2026 Moher, D. (2021). The PRISMA 2020 statement:an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.),372, n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"90089_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13059-016-1103-0","volume":"17","author":"M Jain","year":"2016","unstructured":"Jain, M., Olsen, H. E., Paten, B. & Akeson, M. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 17, 239 (2016).","journal-title":"Genome Biol."},{"issue":"2","key":"90089_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison, A. et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int. J. Technol. Assess. Health Care. 28 (2), 138\u2013144. https:\/\/doi.org\/10.1017\/S0266462312000086 (2012).","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"90089_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jclinepi.2021.04.012","volume":"137","author":"AI Dobrescu","year":"2021","unstructured":"Dobrescu, A. I. et al. Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. J. Clin. Epidemiol. 137, 209\u2013217. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.04.012 (2021).","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"90089_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13643-019-1131-4)","volume":"8","author":"T Mathes","year":"2019","unstructured":"Mathes, T. & Pieper, D. An algorithm for the classification of study designs to assess diagnostic, prognostic and predictive test accuracy in systematic reviews. Syst. Reviews. 8 (1), 226. https:\/\/doi.org\/10.1186\/s13643-019-1131-4) (2019).","journal-title":"Syst. Reviews"},{"issue":"8","key":"90089_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting, P. F. et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155 (8), 529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009 (2011).","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"90089_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks, J. J., Macaskill, P. & Irwig, L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J. Clin. Epidemiol. 58 (9), 882\u2013893. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.01.016 (2005).","journal-title":"J. Clin. Epidemiol."},{"key":"90089_CR21","doi-asserted-by":"publisher","first-page":"e2019007","DOI":"10.4178\/epih.e2019007","volume":"41","author":"SR Shim","year":"2019","unstructured":"Shim, S. R., Kim, S. J. & Lee, J. Diagnostic test accuracy: application and practice using R software. Epidemiol. Health. 41, e2019007. https:\/\/doi.org\/10.4178\/epih.e2019007 (2019). Epub 2019 Mar 28. PMID: 30999739; PMCID: PMC6545496.","journal-title":"Epidemiol. Health"},{"key":"90089_CR22","doi-asserted-by":"publisher","unstructured":"Deng, Q. et al. Nanopore-based metagenomic sequencing for the rapid and precise detection of pathogens among immunocompromised cancer patients with suspected infections. Front. Cell. Infect. Microbiol. 12 https:\/\/doi.org\/10.3389\/fcimb.2022.943859 (2022).","DOI":"10.3389\/fcimb.2022.943859"},{"key":"90089_CR23","doi-asserted-by":"publisher","unstructured":"Fu, Y. et al. Clinical performance of Nanopore targeted sequencing for diagnosing Infectious diseases. Microbiol. Spectr. 10 (2). https:\/\/doi.org\/10.1128\/spectrum.00270-22 (2022).","DOI":"10.1128\/spectrum.00270-22"},{"key":"90089_CR24","doi-asserted-by":"publisher","first-page":"103639","DOI":"10.1016\/j.ebiom.2021.103639","volume":"73","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue. EBioMedicine 73, 103639. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103639 (2021).","journal-title":"EBioMedicine"},{"key":"90089_CR25","doi-asserted-by":"publisher","first-page":"104858","DOI":"10.1016\/j.ebiom.2023.104858","volume":"98","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. A dual-process of targeted and unbiased Nanopore sequencing enables accurate and rapid diagnosis of lower respiratory infections. EBioMedicine 98, 104858\u2013104858. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104858 (2023).","journal-title":"EBioMedicine"},{"issue":"2","key":"90089_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/23744235.2023.2276785","volume":"56","author":"Q Lin","year":"2023","unstructured":"Lin, Q. et al. The application of nanopore targeted sequencing for pathogen diagnosis in bronchoalveolar lavage fluid of patients with pneumonia: a prospective multicenter study. Infect. Dis. 56 (2), 128\u2013137. https:\/\/doi.org\/10.1080\/23744235.2023.2276785 (2023).","journal-title":"Infect. Dis."},{"key":"90089_CR27","doi-asserted-by":"publisher","unstructured":"Liu, Z. et al. Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis. BMC Pulm. Med. 23 (1). https:\/\/doi.org\/10.1186\/s12890-023-02337-3 (2023).","DOI":"10.1186\/s12890-023-02337-3"},{"issue":"176","key":"90089_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.24976\/discov.med.202335176.34","volume":"35","author":"W Luo","year":"2023","unstructured":"Luo, W. et al. Comparison of third-generation sequencing technology and traditional microbiological detection in Pathogen diagnosis of lower respiratory tract infection. Discov. Med. 35 (176), 332\u2013332. https:\/\/doi.org\/10.24976\/discov.med.202335176.34 (2023).","journal-title":"Discov. Med."},{"key":"90089_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.08.20057604","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Same-day simultaneous diagnosis of bacterial and fungal infections in clinical practice by Nanopore targeted sequencing. MedRxiv (Cold Spring Harbor Laboratory). https:\/\/doi.org\/10.1101\/2020.04.08.20057604 (2020).","journal-title":"MedRxiv (Cold Spring Harbor Laboratory)"},{"issue":"9","key":"90089_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/tropicalmed8090441","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Accuracy of Nanopore Sequencing as a diagnostic assay for pulmonary tuberculosis versus Smear, Culture and Xpert MTB\/RIF: a Head-to-head comparison. Trop. Med. Infect. Disease. 8 (9), 441. https:\/\/doi.org\/10.3390\/tropicalmed8090441 (2023).","journal-title":"Trop. Med. Infect. Disease"},{"key":"90089_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijid.2022.06.001","volume":"122","author":"G Yu","year":"2022","unstructured":"Yu, G. et al. Diagnostic accuracy of nanopore sequencing using respiratory specimens in the diagnosis of pulmonary tuberculosis. Int. J. Infect. Dis. 122, 237\u2013243. https:\/\/doi.org\/10.1016\/j.ijid.2022.06.001 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"90089_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2147\/idr.s442229","volume":"17","author":"G Yu","year":"2024","unstructured":"Yu, G., Shen, Y., Yao, L. & Xu, X. Evaluation of Nanopore Sequencing for diagnosing pulmonary tuberculosis using negative smear clinical specimens. Infect. Drug Resist. 17, 673\u2013682. https:\/\/doi.org\/10.2147\/idr.s442229 (2024).","journal-title":"Infect. Drug Resist."},{"key":"90089_CR33","doi-asserted-by":"publisher","unstructured":"Zhang, J. et al. Clinical value of metagenomic next-generation sequencing by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid in suspected community-acquired pneumonia patients. Front. Cell. Infect. Microbiol. 12 https:\/\/doi.org\/10.3389\/fcimb.2022.1021320 (2022).","DOI":"10.3389\/fcimb.2022.1021320"},{"issue":"2","key":"90089_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jiac.2023.09.014","volume":"30","author":"L Zhou","year":"2024","unstructured":"Zhou, L., Zou, X., Hu, Q., Hua, H. & Qi, Q. Determination of the diagnostic accuracy of nanopore sequencing using bronchoalveolar lavage fluid samples from patients with sputum-scarce pulmonary tuberculosis. J. Infect. Chemother. 30 (2), 98\u2013103. https:\/\/doi.org\/10.1016\/j.jiac.2023.09.014 (2024).","journal-title":"J. Infect. Chemother."},{"key":"90089_CR35","doi-asserted-by":"publisher","unstructured":"Cabibbe, A. M. et al. Application of targeted next-generation sequencing assay on a portable sequencing platform for culture-free detection of drug-resistant tuberculosis from clinical samples. J. Clin. Microbiol. 58 (10). https:\/\/doi.org\/10.1128\/jcm.00632-20 (2020).","DOI":"10.1128\/jcm.00632-20"},{"issue":"9","key":"90089_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/antibiotics9090548","volume":"9","author":"J Cervantes","year":"2020","unstructured":"Cervantes, J., Yokobori, N. & Hong, B. Y. Genetic identification and drug-resistance characterization of Mycobacterium tuberculosis using a portable sequencing device. A pilot study. Antibiot. (Basel Switzerland). 9 (9), 548. https:\/\/doi.org\/10.3390\/antibiotics9090548 (2020).","journal-title":"Antibiot. (Basel Switzerland)"},{"key":"90089_CR37","doi-asserted-by":"publisher","unstructured":"Chan, W. S. et al. Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis. BMC Res. Notes. 13 (1). https:\/\/doi.org\/10.1186\/s13104-020-05287-9 (2020).","DOI":"10.1186\/s13104-020-05287-9"},{"key":"90089_CR38","doi-asserted-by":"publisher","unstructured":"Gliddon, H. D. et al. A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, using targeted isothermal amplification and nanopore sequencing. Microbiol. Spectr. 9 (3). https:\/\/doi.org\/10.1128\/spectrum.00610-21 (2021).","DOI":"10.1128\/spectrum.00610-21"},{"key":"90089_CR39","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Gonz\u00e1lez, P. J., Campino, S., Phelan, J. E. & Clark, T. G. Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications. Brief. Bioinform. 23 (5). https:\/\/doi.org\/10.1093\/bib\/bbac256 (2022).","DOI":"10.1093\/bib\/bbac256"},{"issue":"2","key":"90089_CR40","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/s2666-5247(22)00301-9","volume":"4","author":"MB Hall","year":"2023","unstructured":"Hall, M. B. et al. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe. 4 (2), e84\u2013e92. https:\/\/doi.org\/10.1016\/s2666-5247(22)00301-9 (2023).","journal-title":"Lancet Microbe"},{"key":"90089_CR41","doi-asserted-by":"publisher","unstructured":"Mariner-Llicer, C. et al. \u00c1lvaro& Accuracy of an amplicon-sequencing nanopore approach to identify variants in tuberculosis drug-resistance-associated genes. Microbial Genomics, 7(12). (2021). https:\/\/doi.org\/10.1099\/mgen.0.000740","DOI":"10.1099\/mgen.0.000740"},{"key":"90089_CR42","doi-asserted-by":"publisher","unstructured":"Murphy, S. G. et al. Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing. Front. Public. Health. 11 https:\/\/doi.org\/10.3389\/fpubh.2023.1206056 (2023).","DOI":"10.3389\/fpubh.2023.1206056"},{"key":"90089_CR43","doi-asserted-by":"publisher","unstructured":"Smith, C. et al. Assessing nanopore sequencing for clinical diagnostics: a comparison of Next-generation sequencing (NGS) methods for Mycobacterium tuberculosis. J. Clin. Microbiol. 59 (1). https:\/\/doi.org\/10.1128\/jcm.00583-20 (2020).","DOI":"10.1128\/jcm.00583-20"},{"issue":"6","key":"90089_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/clinchem\/hvaa092","volume":"66","author":"K Tafess","year":"2020","unstructured":"Tafess, K. et al. Targeted-sequencing workflows for comprehensive drug Resistance profiling of Mycobacterium tuberculosis cultures using two commercial sequencing platforms: comparison of Analytical and Diagnostic Performance, Turnaround Time, and cost. Clin. Chem. 66 (6), 809\u2013820. https:\/\/doi.org\/10.1093\/clinchem\/hvaa092 (2020).","journal-title":"Clin. Chem."},{"key":"90089_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7588033","volume":"2022","author":"K Zhao","year":"2022","unstructured":"Zhao, K. et al. Rapid Identification of Drug-resistant tuberculosis genes using direct PCR amplification and Oxford Nanopore Technology Sequencing. Can. J. Infect. Dis. Med. Microbiol. 2022, 1\u20138. https:\/\/doi.org\/10.1155\/2022\/7588033 (2022).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"90089_CR46","doi-asserted-by":"publisher","unstructured":"Zhao, M. et al. Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario. Front. Cell. Infect. Microbiol. 14 https:\/\/doi.org\/10.3389\/fcimb.2024.1330788 (2024).","DOI":"10.3389\/fcimb.2024.1330788"},{"key":"90089_CR47","doi-asserted-by":"publisher","first-page":"1349715","DOI":"10.3389\/fmicb.2024.1349715","volume":"15","author":"A Liu","year":"2024","unstructured":"Liu, A. et al. Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study. Front. Microbiol. 15, 1349715. https:\/\/doi.org\/10.3389\/fmicb.2024.1349715 (2024).","journal-title":"Front. Microbiol."},{"issue":"1","key":"90089_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12929-021-00783-x","volume":"28","author":"MC Yu","year":"2021","unstructured":"Yu, M. C. et al. Integrative utility of long read sequencing-based whole genome analysis and phenotypic assay on differentiating isoniazid-resistant signature of Mycobacterium tuberculosis. J. Biomed. Sci. 28 (1), 86. https:\/\/doi.org\/10.1186\/s12929-021-00783-x (2021).","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"90089_CR49","doi-asserted-by":"publisher","first-page":"e0075422","DOI":"10.1128\/spectrum.00754-22","volume":"10","author":"MC Yu","year":"2022","unstructured":"Yu, M. C. et al. Differential Impact of the rpoB Mutant on Rifampin and Rifabutin Resistance signatures of Mycobacterium tuberculosis is revealed using a whole-genome sequencing assay. Microbiol. Spectr. 10 (4), e0075422. https:\/\/doi.org\/10.1128\/spectrum.00754-22 (2022).","journal-title":"Microbiol. Spectr."},{"issue":"3","key":"90089_CR50","doi-asserted-by":"publisher","first-page":"e0157822","DOI":"10.1128\/jcm.01578-22","volume":"61","author":"K Nilgiriwala","year":"2023","unstructured":"Nilgiriwala, K. et al. Genomic sequencing from sputum for Tuberculosis disease diagnosis, lineage determination, and drug susceptibility prediction. J. Clin. Microbiol. 61 (3), e0157822. https:\/\/doi.org\/10.1128\/jcm.01578-22 (2023).","journal-title":"J. Clin. Microbiol."},{"key":"90089_CR51","doi-asserted-by":"publisher","unstructured":"Sun, X. et al. A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens. Front. Cell. Infect. Microbiol. 13 https:\/\/doi.org\/10.3389\/fcimb.2023.1107990 (2023).","DOI":"10.3389\/fcimb.2023.1107990"},{"issue":"5","key":"90089_CR52","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1128\/JCM.02483-16","volume":"55","author":"AA Votintseva","year":"2017","unstructured":"Votintseva, A. A. et al. Same-Day Diagnostic and Surveillance Data for Tuberculosis via whole-genome sequencing of direct respiratory samples. J. Clin. Microbiol. 55 (5), 1285\u20131298. https:\/\/doi.org\/10.1128\/JCM.02483-16 (2017).","journal-title":"J. Clin. Microbiol."},{"key":"90089_CR53","doi-asserted-by":"publisher","unstructured":"Zhang, H. et al. The application of targeted nanopore sequencing for the identification of pathogens and resistance genes in lower respiratory tract infections. Front. Microbiol. 13 https:\/\/doi.org\/10.3389\/fmicb.2022.1065159 (2022).","DOI":"10.3389\/fmicb.2022.1065159"},{"issue":"11","key":"90089_CR54","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","volume":"6","author":"JF Cohen","year":"2016","unstructured":"Cohen, J. F. et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ open. 6 (11), e012799. https:\/\/doi.org\/10.1136\/bmjopen-2016-012799 (2016).","journal-title":"BMJ open."},{"issue":"4","key":"90089_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu, \u015e. K. & Aksel, G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value. Turkish J. Emerg. Med. 23 (4), 195\u2013198. https:\/\/doi.org\/10.4103\/tjem.tjem_182_23 (2023).","journal-title":"Turkish J. Emerg. Med."},{"key":"90089_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fpubh.2017.00307","volume":"5","author":"R Trevethan","year":"2017","unstructured":"Trevethan, R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front. Public. Health. 5, 307. https:\/\/doi.org\/10.3389\/fpubh.2017.00307 (2017).","journal-title":"Front. Public. Health"},{"issue":"11","key":"90089_CR57","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0895-4356(03)00177-x","volume":"56","author":"AS Glas","year":"2003","unstructured":"Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J. & Bossuyt, P. M. The diagnostic odds ratio: a single indicator of test performance. J. Clin. Epidemiol. 56 (11), 1129\u20131135. https:\/\/doi.org\/10.1016\/s0895-4356(03)00177-x (2003).","journal-title":"J. Clin. Epidemiol."},{"issue":"7322","key":"90089_CR58","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/bmj.323.7322.1188a","volume":"323","author":"NJ Blackman","year":"2001","unstructured":"Blackman, N. J. Systematic reviews of evaluations of diagnostic and screening tests. Odds ratio is not independent of prevalence. BMJ (Clinical Res. ed.). 323 (7322), 1188 (2001).","journal-title":"BMJ (Clinical Res. ed.)"},{"issue":"9","key":"90089_CR59","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/sim.6432","volume":"34","author":"F Chen","year":"2015","unstructured":"Chen, F., Xue, Y., Tan, M. T. & Chen, P. Efficient statistical tests to compare Youden index: accounting for contingency correlation. Stat. Med. 34 (9), 1560\u20131576. https:\/\/doi.org\/10.1002\/sim.6432 (2015).","journal-title":"Stat. Med."},{"key":"90089_CR60","doi-asserted-by":"publisher","unstructured":"Rocha et al. (2021). The Neglected contribution of streptomycin to the Tuberculosis drug resistance problem. Genes, 12(12), 2003. (2021). https:\/\/doi.org\/10.3390\/genes12122003","DOI":"10.3390\/genes12122003"},{"key":"90089_CR61","first-page":"6","volume":"7","author":"Y Zhang","year":"2003","unstructured":"Zhang, Y. & Mitchison, D. The curious characteristics of pyrazinamide: a review. Int. J. Tuberc Lung Dis. 7, 6\u201321 (2003).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"9","key":"90089_CR62","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/sim.1099","volume":"21","author":"SD Walter","year":"2002","unstructured":"Walter, S. D. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat. Med. 21 (9), 1237\u20131256. https:\/\/doi.org\/10.1002\/sim.1099 (2002).","journal-title":"Stat. Med."},{"issue":"1","key":"90089_CR63","doi-asserted-by":"publisher","first-page":"21032","DOI":"10.1038\/s41598-022-25314-y","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu, J., Zhang, Q., Dong, Y. Q., Yin, J. & Qiu, Y. Q. Diagnostic accuracy of metagenomic next-generation sequencing in diagnosing infectious diseases: a meta-analysis. Sci. Rep. 12 (1), 21032. https:\/\/doi.org\/10.1038\/s41598-022-25314-y (2022).","journal-title":"Sci. Rep."},{"key":"90089_CR64","doi-asserted-by":"publisher","first-page":"111359","DOI":"10.1016\/j.jclinepi.2024.111359)","volume":"170","author":"SH Bradley","year":"2024","unstructured":"Bradley, S. H., Shinkins, B., Abel, G. & Callister, M. E. J. Interpreting diagnostic accuracy studies based on retrospective routinely collected data. J. Clin. Epidemiol. 170, 111359. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111359) (2024).","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"90089_CR65","doi-asserted-by":"publisher","first-page":"e0316019","DOI":"10.1371\/journal.pone.0316019","volume":"19","author":"J Li","year":"2024","unstructured":"Li, J. Area under the ROC curve has the most consistent evaluation for binary classification. PLOS ONE. 19 (12), e0316019 (2024).","journal-title":"PLOS ONE"},{"key":"90089_CR66","unstructured":"World Health Organization. (\u200e2018)\u200e. The use of next-generation sequencing technologies for the detection of mutations associated with drug resistance in Mycobacterium tuberculosis complex: technical guide. World Health Organization. https:\/\/iris.who.int\/handle\/10665\/274443. License: CC BY-NC-SA 3.0 IGO."},{"key":"90089_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2016.05.004","author":"H Lu","year":"2016","unstructured":"Lu, H., Giordano, F. & Ning, Z. Oxford nanopore MinION sequencing and genome assembly. Genom. Proteom. Bioinform., 14(5), 265\u2013279. https:\/\/doi.org\/10.1016\/j.gpb.2016.05.004 (2016)."},{"issue":"1","key":"90089_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13059-018-1462-9","volume":"19","author":"FJ Rang","year":"2018","unstructured":"Rang, F. J., Kloosterman, W. P. & de Ridder, J. From squiggle to basepair: computational approaches for improving nanopore sequencing read accuracy. Genome Biol. 19 (1), 90. https:\/\/doi.org\/10.1186\/s13059-018-1462-9 (2018).","journal-title":"Genome Biol."},{"issue":"1","key":"90089_CR69","doi-asserted-by":"publisher","first-page":"e0064621","DOI":"10.1128\/JCM.00646-21","volume":"60","author":"A Dippenaar","year":"2022","unstructured":"Dippenaar, A. et al. Nanopore sequencing for mycobacterium tuberculosis: a critical review of the literature, New developments, and future opportunities. J. Clin. Microbiol. 60 (1), e0064621. https:\/\/doi.org\/10.1128\/JCM.00646-21 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"90089_CR70","first-page":"23","volume":"32","author":"CL Hall","year":"2020","unstructured":"Hall, C. L., Zascavage, R. R., Sedlazeck, F. J. & Planz, J. V. Potential applications of nanopore sequencing for forensic analysis. Forensic Sci. Rev. 32, 23 (2020).","journal-title":"Forensic Sci. Rev."},{"issue":"2019","key":"90089_CR71","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cegh.2018.05.005","volume":"7","author":"M Richardson","year":"2019","unstructured":"Richardson, M., Garnera, P. & Donegan, S. Interpretation of subgroup analyses in systematic reviews: a tutorial. Clin. Epidemiol. Global Health. 7 (2019), 192\u2013198 (2019).","journal-title":"Clin. Epidemiol. Global Health"},{"key":"90089_CR72","unstructured":"Higgins, J. P. T. et al. (eds). Cochrane Handbook for systematic reviews of Interventions version 6.4 (updated August 2023). Cochrane, (2023). Available from www.training.cochrane.org\/handbook"}],"updated-by":[{"DOI":"10.1038\/s41598-025-03656-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90089-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90089-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90089-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T15:57:56Z","timestamp":1748275076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90089-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90089-x","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.gpb.2016.05.004","asserted-by":"subject"}],"correction":[{"id-type":"doi","id":"10.1038\/s41598-025-03656-7","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-03656-7","URL":"https:\/\/doi.org\/10.1038\/s41598-025-03656-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11626"}}